UTHR · United Therapeutics Corp
United States · RS rating 89 · As of 2026-11-03
| Price | 601.32 USD |
|---|---|
| 1-day change | +0.9% |
| RS rating (overall / 1M / 3M / 12M) | 89 / 85 / 87 / 78 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 42 / 60 / 53 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +7.5% |
| Sales growth Q/Q | -1.2% |
| Distance from 52-week high | +0.0% |
| Market cap (USD) | $25.1B |